Durvalumab vs Valsartan

Durvalumab vs Valsartan: Overview

This comparison examines the pharmacological differences between Durvalumab and Valsartan.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Valsartan: Angiotensin II type 1 receptor blocker.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Valsartan — 6 hours.

Chemical Properties

Molecular Formula: Valsartan — C24H29N5O3.

Molecular Weight: Valsartan — 435.5190 g/mol.

Type: Durvalumab — Antibody; Valsartan — Small molecule.